1Gelfand JM, Weinstein R, Porter SB, et al.Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol, 2005, 141(12): 1537-1541.
4Picardi A, Mazzotti E, Gaetano P, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics, 2005, 46(6): 556-564.
5Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition. Lancet, 2005, 366(9491 ): 1059-1062.
6FordES, Giles WH, Dietz WH.Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA, 2002, 287(3 ): 356-359.
9Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol, 2007, 157( 1 ): 68-73.
10Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res, 2006, 298(7): 321-328.
